Literature DB >> 24503801

Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.

Giulia Valeria Bianchi, Matteo Duca, Lorenzo Sica, Gabriella Mariani.   

Abstract

A 53-year-old woman was treated, after trastuzumab progression of HER2-positive metastatic disease, with capecitabine plus lapatinib and subsequently with lapatinib alone. To date, she has had persistent remission of disease since 2009.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24503801     DOI： 10.1700/1390.15466

Source DB:  PubMed          Journal:  Tumori        ISSN： 0300-8916            Impact factor:   2.098


  2 in total

Review 1.  Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature.

Authors:  Isabel Ihnenfeld Arciénega; Patrick Imesch; Daniel Fink; Konstantin J Dedes
Journal:  Target Oncol       Date:  2014-12-17       Impact factor: 4.493

2.  Iterative and prolonged remission in metastatic breast cancer using pegylated irinotecan: a case report.

Authors:  Mounia Amzerin; Maha Mokrim; Hassan Errihani; Martine J Piccart
Journal:  J Med Case Rep       Date:  2015-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.